Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
An amendment to this paper has been published and can be accessed via the original article.
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-01-01
|
| Series: | Molecular Cancer |
| Online Access: | https://doi.org/10.1186/s12943-021-01319-5 |